HAEHAEMONETICS CORP同业对比
HAEMONETICS CORP 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE本股 | $5.0B#8 | 52.8x#7 | 5.9x#11 | 3.7x#11 | -2.0%#14 | -42.0%#13 | 11.7%#5 | 0.0%#7 | 6.7%#5 | 7#1 | 118.9%#1 | — |
| BAX | $12.1B#1 | — | 1.9x#4 | 1.1x#1 | 5.7%#13 | -47.5%#14 | -2.7%#10 | -15.4%#10 | -2.3%#9 | 4#9 | — | 2.9%#1 |
| GMED | $10.1B#2 | 19.2x#3 | 2.1x#5 | 3.4x#8 | 16.7%#7 | 422.3%#1 | 16.3%#2 | 11.3%#4 | — | — | — | — |
| PODD | $9.7B#4 | 26.1x#4 | 6.8x#12 | 3.6x#9 | 30.7%#3 | -40.9%#12 | 17.5%#1 | 17.4%#2 | 17.7%#1 | 7#1 | — | — |
| GKOS | $9.8B#3 | — | 14.3x#13 | 19.2x#14 | 32.3%#2 | -28.2%#10 | -39.3%#15 | -27.5%#12 | -34.9%#10 | 3#11 | — | — |
| MMED | $6.1B#5 | — | 1.7x#1 | 2.0x#3 | 14.3%#9 | -56.3%#15 | -6.1%#11 | -9.2%#9 | — | — | — | — |
| TFX | $5.4B#6 | — | 1.9x#3 | 2.7x#5 | 17.2%#6 | -1390.8%#16 | 5.9%#6 | -31.2%#13 | 2.2%#6 | 4#9 | — | 1.1%#2 |
| MMSI | $5.1B#7 | 35.2x#6 | 3.0x#7 | 3.4x#7 | 11.8%#11 | 6.8%#8 | 12.2%#4 | 7.6%#5 | 7.1%#4 | 7#1 | 3.6%#2 | — |
| HTFL | $4.3B#9 | 16.6x#2 | 15.4x#14 | 24.5x#15 | 39.9%#1 | -21.1%#9 | -36.4%#14 | -41.8%#15 | — | — | — | — |
| ICUI | $3.9B#10 | 130.4x#8 | 1.8x#2 | 1.7x#2 | -6.3%#15 | 100.6%#3 | 1.9%#8 | 0.0%#6 | 0.3%#7 | 6#7 | — | — |
| IRTC | $3.7B#12 | — | 19.9x#15 | 5.0x#12 | 26.2%#4 | 60.2%#5 | -7.7%#12 | -24.2%#11 | — | 6#7 | — | — |
| PLSE | $3.8B#11 | — | 38.0x#16 | 10814.5x#16 | — | -35.8%#11 | -21982.6%#16 | -73.1%#16 | — | — | — | — |
| ATRC | $3.0B#13 | 279.7x#9 | 5.8x#10 | 5.6x#13 | 14.9%#8 | 74.4%#4 | -1.8%#9 | -2.2%#8 | -2.3%#8 | 7#1 | — | — |
| UFPT | $2.2B#14 | 30.6x#5 | 4.7x#8 | 3.6x#10 | 19.5%#5 | 15.8%#7 | 15.3%#3 | 14.8%#3 | 13.4%#2 | 7#1 | — | — |
| INSP | $2.1B#15 | 16.3x#1 | 2.6x#6 | 2.3x#4 | 13.6%#10 | 171.8%#2 | 5.6%#7 | 17.6%#1 | 7.1%#3 | 7#1 | — | — |
| NVCR | $1.9B#16 | — | 5.8x#9 | 3.0x#6 | 8.3%#12 | 19.4%#6 | -23.5%#13 | -40.3%#14 | -35.0%#11 | 3#11 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议